The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Ocular Drug Delivery
Open accessAbstract
Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood-retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage form, especially to the posterior segment. Identification of influx transporters on various ocular tissues and designing a transporter-targeted delivery of a parent drug has gathered momentum in recent years. Parallelly, colloidal dosage forms such as nanoparticles, nanomicelles, liposomes, and microemulsions have been widely explored to overcome various static and dynamic barriers. Novel drug delivery strategies such as bioadhesive gels and fibrin sealant-based approaches were developed to sustain drug levels at the target site. Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical application to deliver drugs to the posterior segment may drastically improve drug delivery in the years to come. Current developments in the field of ophthalmic drug delivery promise a significant improvement in overcoming the challenges posed by various anterior and posterior segment diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This method avoids complications of first-pass metabolism and has the advantage of easy administration, sometimes by the patients themselves. However, barriers, such as the pre-corneal tear film, the structure of the cornea, limited volume, lacrimal drainage system, reflex tearing, and aqueous outflow of the eye, reduce the bioavailability of the product to around 5% or less.35,118,119”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600
Self-citationSieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Benival, D. M., Agarwal, R., Rana, D., & Salave, S. (2022) · Current Nanomedicine · doi:10.2174/2468187312666220806133901 · Cited by 7
Advances in microneedles for non-transdermal applications
Cao, X., & Chen, G. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2118711 · Cited by 7
Monocarboxylate Transporters: Role and Regulation in Corneal Diabetes
Shrestha, P., Whelchel, A. E., Nicholas, S. E., Liang, W., Ma, J., & Karamichos, D. (2022) · Analytical Cellular Pathology · doi:10.1155/2022/6718566 · Cited by 7
Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
Jang, M., Kang, M., Lee, E., & Shin, D. (2024) · Pharmaceuticals · doi:10.3390/ph17010111 · Cited by 7
IN VITRO EVIDENCE FOR MYCOPHENOLIC ACID DOSE-RELATED CYTOTOXICITY IN HUMAN RETINAL CELLS
Zacharias, L. C., Damico, F. M., Kenney, M. C., Gasparin, F., Acquesta, F. B., Ventura, D. F., Takahashi, W. Y., & Kuppermann, B. D. (2013) · Retina · doi:10.1097/iae.0b013e31828b91e6 · Cited by 7
Ocular Tissue Distribution of Topically Applied PEGylated and Non-PEGylated Liposomes
Nasir, N. A. A., Alyautdin, R. N., Agarwal, R., Nukolova, N. V., Cheknonin, V., & Ismail, N. M. (2013) · Advanced materials research · doi:10.4028/www.scientific.net/amr.832.1 · Cited by 7
Abdi, F., Arkan, E., Mansouri, K., Shekarbeygi, Z., & Barzegari, E. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116655 · Cited by 7
Shelley, H., Annaji, M., Smith, F., & Babu, R. J. (2021) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0073 · Cited by 7
Ultrasound-Enhanced Transcorneal Drug Delivery for Treatment of Fungal Keratitis
Allison, C., Cellum, B., Karpinecz, B., Nasrallah, F. P., & Zderic, V. (2021) · Cornea · doi:10.1097/ico.0000000000002916 · Cited by 7
Kapanigowda, U. G., Sreeharsha, N., Ramaiah, B., Boggarapu, P. R., & Subramanian, R. (2015) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-015-9239-0 · Cited by 7
Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles
Minami, M., Seiriki, R., Otake, H., Nakazawa, Y., Kanai, K., Tanino, T., & Nagai, N. (2020) · Materials · doi:10.3390/ma13071675 · Cited by 7
RECENT TRENDS IN OPHTHALMIC DRUG DELIVERY
Sharma, R., & Goswami, L. (2013) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.04707 · Cited by 7
Revealing the Potential of Mucoadhesive Ocular Nanoparticles for Enhanced Drug Delivery
Maheshwari, S., Singh, A., Wasim, R., Prajapati, B. G., Malviya, R., & Shazly, G. A. (2024) · Current Nanomedicine · doi:10.2174/0124681873284203240328102643 · Cited by 6
Applications and latest research progress of liposomes in the treatment of ocular diseases
Tang, H., Li, X., Jin, L., Dong, J., Li, Y., Li, C., Zhang, L., & Cheng, F. (2025) · Biointerphases · doi:10.1116/6.0004159 · Cited by 6
Knaggs, K. L. M., Sun, Y., Walz, B. A., Pang, J., & Khan, O. F. (2025) · Therapeutic Delivery · doi:10.1080/20415990.2025.2506977 · Cited by 7
POLYMERS AND HYDROGELS IN EYE SURGERY: MODERN SOLUTIONS FOR TISSUE PROTECTION AND REGENERATION
NISTOR, A. C., Ștefan, C. S., & Topor, G. (2024) · Medicine and Materials · doi:10.36868/medmater.2024.04.03.127 · Cited by 6
Disulfide-Appended siRNA Nanoeyedrops: Noninvasive Gene Therapy for Targeting Retinal Angiogenesis
Liu, S., Wang, D., Ye, S., Zhang, J., Du, B., Lian, Z., Yang, W. H., Zhou, J. J., Chen, Q., Li, J., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c14313 · Cited by 7
Engineering chitosan-functionalized liposomes for targeted drug delivery and biomedical applications
Ren, Z., Gao, W., Li, X., Jing, Y., Gu, M., Xing, P., Jing, Z., Ashrafizadeh, M., Ren, J., Orive, G., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150563 · Cited by 8
Aghamirsalim, M., Mobaraki, M., Jabbarvand, M., & Sahraian, A. (2026) · Translational Vision Science & Technology · doi:10.1167/tvst.15.3.2 · Cited by 7
Kong, X., Jia, Y., Wang, H., Li, R., Chu-jie, L., Cheng, S., Chen, T., Mai, Y., Nie, Y., Deng, Y., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01308 · Cited by 6
Advanced hydrogel-based platform for ocular drug delivery
Nangare, S., Pantwalawalkar, J. R., Jadhav, N. R., Nnamani, P. O., Khan, Z. G., Patil, P. O., & Bari, S. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15264-1.00011-7 · Cited by 6
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug
Shree, D., Patra, C. N., & Sahoo, B. M. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230816090046 · Cited by 7
Vertloo, L. R. V., Sebbag, L., Allbaugh, R. A., Allenspach, K., Borts, D. J., & Mochel, J. P. (2024) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.23.12.0707 · Cited by 6
Nanocarrier-based Drug Delivery of Brinzolamide for Ocular Diseases: A Mini-Review
Maurya, R., Vikal, A., Patel, P., Narang, R. K., & Kurmi, B. D. (2024) · Current Nanomedicine · doi:10.2174/0124681873294344240408061056 · Cited by 6
Ocular drug-metabolizing enzymes: focus on esterases
Hammid, A., & Honkakoski, P. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2368247 · Cited by 7
Zhang, F., Tan, M. J. A., Hu, Z., Zhang, Y.-T., Qi, X., Che, Y.-T., Li, J., Zhang, S., & Li, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138428 · Cited by 7
A look to the future: cyclodextrins and cyclodextrin-based drug delivery to the retina
Jansook, P., Sigurðsson, H. H., & Loftsson, Þ. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2482049 · Cited by 6
Transfersomes: a next-generation drug delivery system for topical ocular drug delivery
Bhujbal, S. S., Rupenthal, I. D., Patravale, V. B., & Agarwal, P. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2497829 · Cited by 6
Recent Overview of Ocular Patents
Gaudana, R., Gokulgandhi, M. R., Boddu, S. H. S., & Mitra, A. K. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112800672921 · Cited by 6
Self-citationKeratorefractive Effect of High Intensity Focused Ultrasound Keratoplasty on Rabbit Eyes
Du, Z., Yan, P., Luo, Q., Zhang, D., & Zhang, Y. (2016) · Journal of Ophthalmology · doi:10.1155/2016/5260531 · Cited by 6
Narrative review-drug delivery in age-related macular degeneration
Israilevich, R. N., Mahmoudzadeh, R., Salabati, M., & Xu, D. N. (2021) · Annals of Eye Science · doi:10.21037/aes-21-8 · Cited by 6
Chan, D. W.-H., Won, G.-J., Read, A. T., Ethier, C. R., Thackaberry, E. A., Crowell, S. R., Booler, H. S., Bantseev, V., & Sivak, J. M. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0734 · Cited by 6
Teal, C. J., Ho, M. T., Huo, L., Harada, H., Bahlmann, L. C., Léveillard, T., Monnier, P. P., Ramachandran, A., & Shoichet, M. S. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.03.003 · Cited by 6
Routes of Nano-drug Administration and Nano-based Drug Delivery System and Toxicity
Gopu, B., Pandian, R., Sevvel, A., & Shukla, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-7834-0_25 · Cited by 7
Innovative advancement of contact lenses for noninvasive diagnosis and therapy: A mini review
Wen, X., Liu, Q., & Zhang, M. (2023) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.40 · Cited by 6
Deshmukh, R., Singh, R., & Mishra, S. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v41.i3.10 · Cited by 7
Drug discovery in glaucoma and the role of animal models
McNally, S., & O'Brien, C. J. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2013.12.002 · Cited by 6
Mohammadpour, M., Jabbarvand, M., Delrish, E., & Khoshzaban, A. (2013) · Journal of Medical Hypotheses and Ideas · doi:10.1016/j.jmhi.2013.06.003 · Cited by 6
Eye gels for ophthalmic delivery
McKenzie, B. K., & Kay, G. (2015) · Expert Review of Ophthalmology · doi:10.1586/17469899.2015.1015993 · Cited by 6
Multidimensional Ophthalmic Nanosystems for Molecular Detection and Therapy of Eye Disorders
Vyas, S., Kakade, P., Chogale, M. M., Disouza, J., & Patravale, V. B. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531171052 · Cited by 6
Sobczyński, J., & Bielecka‐Papierz, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816504-1.00006-5 · Cited by 6
Spertus, C. B., Gomes, F. E., Martin‐Flores, M., Parry, S. A., & Ledbetter, E. C. (2020) · Veterinary Ophthalmology · doi:10.1111/vop.12770 · Cited by 6
Pescina, S., Sala, M., Scala, M. C., Santi, P., Padula, C., Campiglia, P., Ostacolo, C., & Nicoli, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080728 · Cited by 6
Role of Formulation Parameters on Intravitreal Dosing Accuracy Using 1 mL Hypodermic Syringes
Weinmann, C., Sediq, A. S., Vogt, M., Mahler, H., Joerg, S., Rodríguez, S., Mathaes, R., & Jere, D. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02880-2 · Cited by 6
Efficacy of systemic administration of riboflavin on a rabbit model of corneal alkali burn
Zhuk, M., Lobashova, K., Żuk, O., & Wierzba, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-74484-0 · Cited by 6
Microfluidics- The State-of-the-Art Technology for Pharmaceutical Application
Verma, A., & Bhattacharya, S. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.073 · Cited by 6
Ramos, M. F., Teixeira, L. B. C., Brandt, C. R., & Auyeung-Kim, D. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_14 · Cited by 6
Abd-Elmonem, E. M., Makky, A. M. A., Anter, A., Abd-Elsalam, W. H., & Khalil, I. A. H. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104614 · Cited by 6
Routes of administration of insulin
Sonia, T. A., & Sharma, C. P. (2014) · Elsevier eBooks · doi:10.1533/9781908818683.59 · Cited by 6
Papangkorn, K., Higuchi, J. W., Brar, B., & Higuchi, W. I. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82388 · Cited by 6
Ansari, M., Kulkarni, Y. A., & Singh, K. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2469321 · Cited by 5
Formulation design of quercetin-loaded polyvinyl alcohol nanofibres for ocular drug delivery
Bashir, R., Gani, A., Shah, A. S., Shafi, H., Fazili, A. A., Ali, T., Raza, S. N., Kawoosa, S., & Khan, N. A. (2025) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2025.100244 · Cited by 5
Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics
Singh, C. P., Rai, P. K., Kumar, M., Tiwari, V., Tiwari, A., Sharma, A., & Sharma, K. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230727102213 · Cited by 5
Silvestri, T., Daruich, A., Palma, F. D. E. D., Mollo, V., Naud, M. C., Aleo, D., Spitaleri, F., Kroemer, G., Béhar‐Cohen, F., Biondi, M., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00276 · Cited by 5
Carter, R. T., Swetledge, S., Navarro, S., Liu, C.-C., Ineck, N. E., Lewin, A. C., Donnarumma, F., Bodoki, E., Stout, R. W., Astete, C. E., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306640 · Cited by 5
Nanotechnological approaches to improve corticosteroids ocular therapy
Formica, M. L., Scerbo, J. M. P., Alfonso, H. G. A., Palmieri, P. T., Ribotta, J., & Palma, S. D. (2024) · Methods · doi:10.1016/j.ymeth.2024.12.008 · Cited by 5
Shen, J., Moats, R. A., Pollack, H. A., Robinson, M. R., & Attar, M. (2020) · Ophthalmology and Therapy · doi:10.1007/s40123-020-00285-3 · Cited by 5
In-Situ Forming Polymeric Drug Delivery Systems for Ophthalmic Use: An Overview
Chhetri, P., Chakraborty, P., Das, D., & Afnan, T. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i3-s.4874 · Cited by 5
Therapeutic Ultrasound for Topical Corneal Delivery of Macromolecules
Almogbil, H. H., Montecinos-Franjola, F., Daszynski, C., Conlon, W. J., Hachey, J. S., Corazza, G., Rodriguez, E. A., & Zderic, V. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.8.23 · Cited by 5
Design and Evaluation of Solid Lipid Nanoparticle Eye Drops Containing VRN for Ocular Drug Delivery
Mahal, R. K., & Al-Gawhari, F. J. (2022) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.12.4.36 · Cited by 5
A COMPREHENSIVE REVIEW ON PRONIOSOMES: A NEW CONCEPT IN OCULAR DRUG DELIVERY
PATEL, A., Havelikar, U. A., Sharma, V. K., YADAV, S., RATHEE, S., GHOSH, B., Gill, K., SINGH, G., SHARMA, L., & Kolay, A. (2023) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2023v15i5.3048 · Cited by 5
Ako-Adounvo, A.-M., & Karla, P. K. (2024) · Journal of Clinical & Translational Ophthalmology · doi:10.3390/jcto2010001 · Cited by 5
Shapiro, J. N., Armenti, S. T., LEVINE, H. D., Hood, C. T., & Mian, S. I. (2024) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2024.07.030 · Cited by 5
Wang, Z., Zhao, H., Ma, J., & Xu, X. (2014) · Cornea · doi:10.1097/ico.0000000000000032 · Cited by 5
Challenges and Strategies in Drug Residue Measurement (Bioanalysis) of Ocular Tissues
Velagaleti, P., & Buonarati, M. H. (2013) · Methods in pharmacology and toxicology · doi:10.1007/7653_2013_6 · Cited by 5
Sigalov, A. B. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.06.004 · Cited by 5
Gene Therapy for Inherited Retinopathies: Update on Development Progress
Sun, S. Y., & Montezuma, S. R. (2018) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126418783934 · Cited by 5
Evolving nanotechnological trends in the management of mycotic keratitis
Rai, M., Grupenmacher, A. T., Ingle, A. P., Paralikar, P., Gupta, I. R., & Alves, M. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2018.5416 · Cited by 5
Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues
da Silva, P. H. R., Silva‐Cunha, A., Pianetti, G. A., & Fernandes, C. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122388 · Cited by 5
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
Matossian, C., Stephens, J. D., Rhee, M. K., Smith, S. E., Majmudar, P. A., Gollamudi, S., Patel, R. H., Rosselson, M., Bauskar, A., Montieth, A., et al. (2022) · Clinical ophthalmology · doi:10.2147/opth.s372440 · Cited by 5
Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases
Giri, S., Badwaik, H. R., & Giri, T. K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104867 · Cited by 5
AN INSIGHT TO OPHTHALMIC IN-SITU GEL: AN OVERVIEW
Thakur, R. R., & Mohit, S. (2012) · International Research Journal of Pharmacy · Cited by 5
Prieto, E., Vispe, E., Otín, S., García‐Martín, E., Polo, V., Fraile, J. M., Pablo, L. E., & Mayoral, J. A. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1183795 · Cited by 5
Ethington, J., Goldmeier, D., & Gaynes, B. I. (2017) · Cornea · doi:10.1097/ico.0000000000001125 · Cited by 5
Alsharabasy, A. M. (2017) · Archives of Biotechnology and Biomedicine · doi:10.29328/journal.hjb.1001004 · Cited by 5
Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy
Sharma, D. S., Singh, S. K., Thakur, D., Arya, K. R., Khursheed, R., & Wadhwa, S. (2019) · Current Drug Therapy · doi:10.2174/1574885514666191007101007 · Cited by 5
Mehta, J. R., Takaoka, A., Zyablitskaya, M., Nagasaki, T., & Paik, D. C. (2019) · Bioscience Reports · doi:10.1042/bsr20191941 · Cited by 5
Computational Approaches for Drug Delivery of Nanoparticles
Sharma, U., Khambete, H., Singh, N., Jain, S., Jain, N., & Dua, K. (2024) · doi:10.1002/9781394159338.ch9 · Cited by 5
Diress, M., Ionescu, C. M., Foster, T., Lim, P., Sen, L. Y., Kovačević, B., Wagle, S. R., Mooranian, A., & Al‐Salami, H. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107172 · Cited by 5
Rajbhar, N., Nijhawan, H. P., & Yadav, K. S. (2026) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2026.2639595 · Cited by 4
Comparing Intracanalicular and Topical Steroid Use in Patients Undergoing Pterygium Surgery
Rhee, M. K., Zakher, M., Najac, M., Arias, H., Jo, J. J., Gorham, R., & Moadel, K. (2024) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0000000000001075 · Cited by 4
Vitreous humor in the forensic toxicology of quetiapine and its metabolites
Moschovakou, D., Ntoupa, S.-P., Dona, A., Athanaselis, S., Spiliopoulou, C., Nikolaou, P., & Papoutsis, I. I. (2024) · Forensic Toxicology · doi:10.1007/s11419-024-00687-z · Cited by 4
Mercadal, P. A., Alfonso, H. G. A., Formica, M. L., Palma, S. D., & González, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106609 · Cited by 4
Optimizing intracameral injection for targeted gene therapy and glaucoma model development
Chen, S., Cong, L., Zhu, X., Qi, B., Zhou, Q., Shi, W., & Zhang, B. N. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110408 · Cited by 4
Xuan, S., Yang, T., Ba, M., Zhang, W., Yang, J., Pei, X., Qi, D., Lu, D., Huang, S., & Li, Z. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.15.50 · Cited by 4
Muñoz-Villaescusa, C., van der Ven, D. L., Quetzeri-Santiago, M. A., & Rivas, D. F. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115792 · Cited by 4
Chitosan-Based Gels for Ocular Drug Delivery
Islam, M. M., Biswas, S., Islam, M. S., Shahruzzaman, M., Hasan, M. M., Islam, M. D., Haque, P., & Rahman, M. M. (2022) · Springer eBooks · doi:10.1007/978-981-16-4787-1_9 · Cited by 4
Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension
Khopade, A. J., Halder, A., Patel, V., Upadhyay, S., BURADE, V. S., Pateliya, B., Panchal, S., Mandhane, S. N., Awati, C., & Zope, M. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2023.0038 · Cited by 4
Comparison of RCI001 and corticosteroid on the effects on intraocular pressure in mice
Kim, S. H., Ku, Y. A., Yoo, C., Kim, Y. H., & Kim, D. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1256569 · Cited by 4
Noninvasive Framework Nucleic Acid Eye Drops for Retinal Administration
Zhu, S., Yan, Q., Wang, L., Zhu, Y., & Luo, S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00760 · Cited by 4
Microneedles: A minimally invasive delivery system for ocular treatment
Jathar, J., Mahajan, H. S., & Nerkar, P. P. (2024) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2024.05.007 · Cited by 4
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies
Khan, M. S., Murthy, A. N., & Ahmed, T. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-03001-7 · Cited by 4
Man-Ha, C. H. A. N., Tseng, C., Huang, W., & Lin, C.-T. (2025) · Journal of Veterinary Medical Science · doi:10.1292/jvms.24-0250 · Cited by 4
Gautam, N., Sharma, P., Yadav, N., Rajeswari, J., & Kesavan, K. (2025) · Current Eye Research · doi:10.1080/02713683.2025.2469243 · Cited by 4
Lanzini, M., Curcio, C., Spoerl, E., Calienno, R., Mastropasqua, A., Colasante, M., Mastropasqua, R., Nubile, M., & Mastropasqua, L. (2016) · International Ophthalmology · doi:10.1007/s10792-016-0266-8 · Cited by 4
Nanomaterials for Treating Ocular Diseases
Yu, G.-P., Vaidya, A. M., Sun, D., & Lu, Z. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_19 · Cited by 4
Sunkireddy, P., Sriramoju, B., Roy, K., Kanwar, R. K., & Kanwar, J. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-95807-1_9 · Cited by 4
Ocular Delivery of Peptides and Proteins
Dahiya, R., & Dahiya, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-95807-1_24 · Cited by 4
Controlled drug release from a spheroidal matrix
Simon, L., & Ospina, J. (2018) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2018.11.048 · Cited by 4
Design and In Vitro Evaluation of a Slow-Release Intraocular Implant of Betamethasone
Ramsheh, Z. S. R., Mohtashami, Z., Kargar, N., Javar, H. A., Tehrani, M. R., & Dorkoosh, F. A. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02048-0 · Cited by 6
Metadata
- Authors
- Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K.
- Affiliations
- University of Missouri–Kansas City (US)
- Corresponding author
- Mitra, Ashim K.
- Venue
- The AAPS Journal
- Published
- 2010-05-01
- Volume
- 12
- Issue
- 3
- Pages
- 348-360
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC2895432
- OpenAlex
- W2018516156
- Cited by
- 1,406
- References
- 256
- Citations by year
- 2026: 114 · 2025: 114 · 2024: 98 · 2023: 118 · 2022: 110 · 2021: 126 · 2020: 116 · 2019: 93 · 2018: 100 · 2017: 96 · 2016: 82 · 2015: 60 · 2014: 54 · 2013: 58 · 2012: 32
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY009171, R01EY10659-12, R01EY010659, R01-EY09171-14)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ocular drug delivery, blood-aqueous barrier, blood-retinal barrier, cornea, sclera, retina, choroidal blood flow, lymphatic clearance, efflux pumps, influx transporters, nanoparticles, nanomicelles, liposomes, microemulsions, bioadhesive gel, fibrin glue, sustained drug release, topical drug delivery, posterior segment, anterior segment
- MeSH terms
- Administration, Topical, Colloids, Eye, Half-Life, Humans, Iontophoresis, Melanins, Pharmacokinetics, Ultrasonics, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review